Welcome to Abyrx, where precision converges with innovation in the realm of medical advancements. Founded in 2013, Abyrx initiated its journey by acquiring the HEMASORB Resorbable Hemostatic Bone Putty portfolio and securing rights to advance Bezwada Biomedical’s cutting-edge polymer technology for bone applications. Since then, our focus has remained steadfast on pioneering the development, manufacturing, and delivery of advanced biomaterials and therapeutic devices tailored for surgical procedures.
Nestled in the picturesque Irvington, NY, Abyrx operates as a privately-held entity, propelled by a fervent desire to revolutionize healthcare solutions. Our commitment to excellence is evident in our extensive portfolio, safeguarded by over 50 issued and pending patents. Embark on a journey into the future of medical technology with Abyrx, where each innovation is meticulously crafted to transform lives and elevate patient outcomes.